The objective of this study was to compare the safety and efficacy of a polymer‐free sirolimus coated, ultrathin strut drug eluting stent (PF‐SES) to its uncoated bare‐metal stent (BMS) platform… Click to show full abstract
The objective of this study was to compare the safety and efficacy of a polymer‐free sirolimus coated, ultrathin strut drug eluting stent (PF‐SES) to its uncoated bare‐metal stent (BMS) platform of identical stent architecture.
               
Click one of the above tabs to view related content.